BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23099380)

  • 1. Texas cancer fund seeks fresh start.
    Baker M
    Nature; 2012 Oct; 490(7421):459-60. PubMed ID: 23099380
    [No Abstract]   [Full Text] [Related]  

  • 2. Banish cronyism.
    Nature; 2012 Oct; 490(7421):446. PubMed ID: 23099363
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomedicine. A Texas wrangle over cancer research funds.
    Kaiser J
    Science; 2012 May; 336(6083):789-90. PubMed ID: 22605723
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomedical research: Texas potential.
    Beil L
    Nature; 2012 Nov; 491(7423):289-90. PubMed ID: 23139939
    [No Abstract]   [Full Text] [Related]  

  • 5. Newsmaker interview. Texas transplant Alfred Gilman guides $3 billion cancer project. Interview by Jocelyn Kaiser.
    Gilman A
    Science; 2009 May; 324(5929):868. PubMed ID: 19443755
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer research. Texas voters asked to approve $3 billion cancer initiative.
    Kaiser J
    Science; 2007 Aug; 317(5842):1154-5. PubMed ID: 17761853
    [No Abstract]   [Full Text] [Related]  

  • 7. Why China needs an NIH.
    Nature; 2004 Apr; 428(6984):679. PubMed ID: 15085093
    [No Abstract]   [Full Text] [Related]  

  • 8. Stem cells. California's bold $3 billion initiative hits the ground running.
    Holden C
    Science; 2005 Jan; 307(5707):195. PubMed ID: 15653479
    [No Abstract]   [Full Text] [Related]  

  • 9. Financial conflicts of interest in biomedical research: the need to improve the system.
    Wang AT; Montori VM; Murad MH
    Drug News Perspect; 2010 Nov; 23(9):607-12. PubMed ID: 21152455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer research. Texas's $3 billion fund lures scientific heavyweights.
    Kaiser J
    Science; 2011 May; 332(6033):1019-20. PubMed ID: 21617048
    [No Abstract]   [Full Text] [Related]  

  • 11. Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward.
    Prasad V; Rajkumar SV
    Blood Cancer J; 2016 Nov; 6(11):e489. PubMed ID: 27813537
    [No Abstract]   [Full Text] [Related]  

  • 12. Portugal: navigating new waters.
    Abbott A
    Nature; 2008 Apr; 452(7187):528-9. PubMed ID: 18385710
    [No Abstract]   [Full Text] [Related]  

  • 13. Institutional Conflicts of Interest and Public Trust.
    Cigarroa FG; Masters BS; Sharphorn D
    JAMA; 2018 Dec; 320(22):2305-2306. PubMed ID: 30428024
    [No Abstract]   [Full Text] [Related]  

  • 14. Translational research: a case history.
    Pearson H
    Nature; 2008 Jun; 453(7197):846-9. PubMed ID: 18548045
    [No Abstract]   [Full Text] [Related]  

  • 15. Saudi-Italian biomedical institute gets go-ahead.
    Abbott A
    Nature; 2007 Dec; 450(7171):772-3. PubMed ID: 18063964
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflict of interest.
    Mamalis N
    J Cataract Refract Surg; 2011 Mar; 37(3):431-2. PubMed ID: 21333864
    [No Abstract]   [Full Text] [Related]  

  • 17. Director quits as cash cutbacks hit Californian labs.
    Dalton R
    Nature; 2004 Jan; 427(6972):274. PubMed ID: 14737130
    [No Abstract]   [Full Text] [Related]  

  • 18. Research funding. Canadian institutes get windfall without the bother of competition.
    Kondro W
    Science; 2007 Mar; 315(5820):1779-80. PubMed ID: 17395801
    [No Abstract]   [Full Text] [Related]  

  • 19. France. Will French science swallow Zerhouni's strong medicine?
    Enserink M
    Science; 2008 Nov; 322(5906):1312. PubMed ID: 19039109
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflicts of interest in medical ethics.
    Diamond EF
    Ethics Med; 2004; 20(3):133-9. PubMed ID: 15675074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.